Pharmacokinetics and renal clearance of sulfamethazine, sulfamerazine, and sulfadiazine and their N4-acetyl and hydroxy metabolites in horses.

This study investigates how three types of sulfa antibiotics – sulfamethazine (SMZ), sulfamerazine (SMR), and sulfadiazine (SDZ) – are processed in the body of horses, including how they’re metabolized and cleared by the kidneys, and how this affects their efficacy as antibiotics.

Summary of Research

• The research involved studying the concentration of the drugs and their metabolic derivatives in the plasma (a component of the blood) and urine of horses over a period of time.
• A crossover trial design was used, meaning that the horses were administered each of the three drugs at different times with a break in between to allow any previous drug intake to leave their system.

Plasma Disposition and Protein Binding

• It was found that the concentration of the drugs in the plasma declined in a similar way to their metabolic derivatives. This means that as the drug was broken down by the body (metabolized), the resulting compounds remained in the blood for a similar length of time to the original drug.
• The extent to which SMZ and SMR were metabolized was greater than SDZ. This suggests that the body processes SDZ differently – potentially due to a slight difference in its chemical structure.

Urinary Recovery and Renal Clearance

• The rate at which the drugs were eliminated through the kidneys, known as renal clearance, was also studied. It was found that the derivatives eliminated in urine had higher renal clearance values than the original drugs, indicating that the body was quicker at clearing the metabolites than the parent drug.
• Significantly, the most common metabolite for all three drugs was heavily subject to a process called glucuronidation – a key stage in drug metabolism that makes compounds more water-soluble and thus easier for the body to eliminate.

Effects on Antibacterial Activity

• One important finding of the study relates to how the drugs’ metabolism affects their antibacterial activity. The presence of large amounts of metabolites in the plasma and urine appeared to reduce the potential effect of the original antibiotics.
• Specifically, it was found that the high concentration of N4-acetyl and hydroxy metabolites in the plasma and urine of the horses reduced the antibacterial activity of SMZ and SMR.
• The SDZ showed slightly lower concentrations in the plasma and urine than those measured by high-performance liquid chromatography, indicating that SDZ was less metabolized and thus potentially more effective as an antibiotic.